These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6824571)

  • 121. [Breast cancer treatment with testosterone; clinical, anatomical-pathological and emotional effects].
    CALEFF IM
    Clin Nuova Rass Prog Med Int; 1948 Jan; 6(1):21-8. PubMed ID: 18866045
    [No Abstract]   [Full Text] [Related]  

  • 122. Fat/fiber intakes and sex hormones in healthy premenopausal women in USA.
    Aubertin-Leheudre M; Gorbach S; Woods M; Dwyer JT; Goldin B; Adlercreutz H
    J Steroid Biochem Mol Biol; 2008 Nov; 112(1-3):32-9. PubMed ID: 18761407
    [TBL] [Abstract][Full Text] [Related]  

  • 123. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.
    Lee SA; Haiman CA; Burtt NP; Pooler LC; Cheng I; Kolonel LN; Pike MC; Altshuler D; Hirschhorn JN; Henderson BE; Stram DO
    BMC Med Genet; 2007 Dec; 8():72. PubMed ID: 18053149
    [TBL] [Abstract][Full Text] [Related]  

  • 124. The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer.
    Lillie EO; Bernstein L; Ursin G
    Breast Cancer Res; 2003; 5(3):164-73. PubMed ID: 12793900
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Circulating testosterone and prostate-specific antigen in nipple aspirate fluid and tissue are associated with breast cancer.
    Sauter ER; Tichansky DS; Chervoneva I; Diamandis EP
    Environ Health Perspect; 2002 Mar; 110(3):241-6. PubMed ID: 11882474
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Urinary androgens and breast cancer risk: results from a long-term prospective study based in Guernsey.
    Wang DY; Allen DS; De Stavola BL; Fentiman IS; Brussen J; Bulbrook RD; Thomas BS; Hayward JL; Reed MJ
    Br J Cancer; 2000 May; 82(9):1577-84. PubMed ID: 10789728
    [TBL] [Abstract][Full Text] [Related]  

  • 127. A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey.
    Thomas HV; Key TJ; Allen DS; Moore JW; Dowsett M; Fentiman IS; Wang DY
    Br J Cancer; 1997; 76(3):401-5. PubMed ID: 9252211
    [TBL] [Abstract][Full Text] [Related]  

  • 128. A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.
    Ursin G; London S; Stanczyk FZ; Gentzschein E; Paganini-Hill A; Ross RK; Pike MC
    Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):601-5. PubMed ID: 9168002
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Nutrition, hormones, and breast cancer: is insulin the missing link?
    Kaaks R
    Cancer Causes Control; 1996 Nov; 7(6):605-25. PubMed ID: 8932921
    [TBL] [Abstract][Full Text] [Related]  

  • 130. The relation of reported alcohol ingestion to plasma levels of estrogens and androgens in premenopausal women (Maryland, United States).
    Dorgan JF; Reichman ME; Judd JT; Brown C; Longcope C; Schatzkin A; Campbell WS; Franz C; Kahle L; Taylor PR
    Cancer Causes Control; 1994 Jan; 5(1):53-60. PubMed ID: 8123779
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Hormone levels in older women: a study of post-menopausal breast cancer patients and healthy population controls.
    Bernstein L; Ross RK; Pike MC; Brown JB; Henderson BE
    Br J Cancer; 1990 Feb; 61(2):298-302. PubMed ID: 2138030
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Serum hormone levels in British and rural Chinese females.
    Wang DY; Key TJ; Pike MC; Boreham J; Chen J
    Breast Cancer Res Treat; 1991 May; 18 Suppl 1():S41-5. PubMed ID: 1873556
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Prolactin and total lactogenic hormone measured by microbioassay and immunoassay in breast cancer.
    Maddox PR; Jones DL; Mansel RE
    Br J Cancer; 1992 Mar; 65(3):456-60. PubMed ID: 1558804
    [TBL] [Abstract][Full Text] [Related]  

  • 134. [Steroid receptor levels in human breast carcinomas in relation to serum hormone levels in postmenopausal patients (author's transl)].
    Reiner G; Bieglmayer C; Jakesz R; Kees A; Kolb R; Spona J
    Wien Klin Wochenschr; 1981 May; 93(11):339-42. PubMed ID: 6791390
    [TBL] [Abstract][Full Text] [Related]  

  • 135. High testosterone and low progesterone circulating levels in premenopausal patients with hyperplasia and cancer of the breast.
    Secreto G; Recchione C; Fariselli G; Di Pietro S
    Cancer Res; 1984 Feb; 44(2):841-4. PubMed ID: 6537901
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Endocrine status in stage II vs. advanced premenopausal and postmenopausal breast cancer patients.
    Bhatavdekar JM; Patel DD; Shah NG; Giri DD; Vora HH; Karelia NH; Trivedi SN; Ghosh N; Suthar TP
    Neoplasma; 1992; 39(1):39-42. PubMed ID: 1388248
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Circulating levels of testosterone, 17 beta-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients.
    Secreto G; Recchione C; Cavalleri A; Miraglia M; Dati V
    Br J Cancer; 1983 Feb; 47(2):269-75. PubMed ID: 6824571
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Peptide and steroid hormone levels in pre- and postmenopausal breast carcinoma.
    Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH
    Neoplasma; 1987; 34(1):95-9. PubMed ID: 3104809
    [TBL] [Abstract][Full Text] [Related]  

  • 139.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 140.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.